ATE492286T1 - Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität - Google Patents
Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivitätInfo
- Publication number
- ATE492286T1 ATE492286T1 AT06711432T AT06711432T ATE492286T1 AT E492286 T1 ATE492286 T1 AT E492286T1 AT 06711432 T AT06711432 T AT 06711432T AT 06711432 T AT06711432 T AT 06711432T AT E492286 T1 ATE492286 T1 AT E492286T1
- Authority
- AT
- Austria
- Prior art keywords
- immunological
- poly
- tumor activity
- peptide derived
- epitope peptide
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 108010022394 Threonine synthase Proteins 0.000 title 1
- 102000005497 Thymidylate Synthase Human genes 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960002949 fluorouracil Drugs 0.000 abstract 1
- -1 for example Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000064A ITRM20050064A1 (it) | 2005-02-16 | 2005-02-16 | Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative. |
| PCT/IT2006/000078 WO2006087756A2 (en) | 2005-02-16 | 2006-02-15 | Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE492286T1 true ATE492286T1 (de) | 2011-01-15 |
Family
ID=36604211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06711432T ATE492286T1 (de) | 2005-02-16 | 2006-02-15 | Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8344100B2 (de) |
| EP (1) | EP1848456B1 (de) |
| JP (1) | JP4943348B2 (de) |
| CN (1) | CN101137392A (de) |
| AT (1) | ATE492286T1 (de) |
| AU (1) | AU2006215260B2 (de) |
| CA (1) | CA2598292C (de) |
| DE (1) | DE602006019057D1 (de) |
| ES (1) | ES2357548T3 (de) |
| IL (1) | IL185101A0 (de) |
| IT (1) | ITRM20050064A1 (de) |
| MX (1) | MX2007009896A (de) |
| NZ (1) | NZ560511A (de) |
| RU (1) | RU2007134338A (de) |
| WO (1) | WO2006087756A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20050064A1 (it) | 2005-02-16 | 2006-08-17 | Univ Siena | Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative. |
| HUE032379T2 (en) * | 2007-07-27 | 2017-09-28 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
| WO2010138955A2 (en) | 2009-05-29 | 2010-12-02 | University Of Florida Research Foundation, Inc. | Methods and compositions for treating neoplasia |
| CN101948508B (zh) * | 2010-09-09 | 2012-07-04 | 郑州大学 | Piwil2抗肿瘤ctl表位肽及其应用 |
| RU2507265C2 (ru) * | 2012-05-12 | 2014-02-20 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической иммунологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИКИ" СО РАМН) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pCI-UB-POLYEPI, СОДЕРЖАЩАЯ ЭПИТОПЫ ОПУХОЛЬ-АССОЦИИРОВАННЫХ АНТИГЕНОВ ДЛЯ КОЛОРЕКТАЛЬНОГО РАКА, И СПОСОБ ЕЕ ПРИМЕНЕНИЯ ДЛЯ СТИМУЛЯЦИИ СПЕЦИФИЧЕСКОГО ПРОТИВООПУХОЛЕВОГО ИММУННОГО ОТВЕТА ПРОТИВ КЛЕТОК КОЛОРЕКТАЛЬНОГО РАКА |
| CN113827740A (zh) * | 2021-09-17 | 2021-12-24 | 青岛农业大学 | 一种水溶性复合疫苗佐剂的筛选方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593456B1 (en) * | 1996-11-06 | 2003-07-15 | The Regents Of The University Of California | Tumor necrosis factor receptor releasing enzyme |
| US7462354B2 (en) | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
| US7378495B2 (en) * | 2002-10-21 | 2008-05-27 | Pevion Biotech, Ltd. | PTH-rP related peptide cancer therapeutics |
| ITRM20050064A1 (it) | 2005-02-16 | 2006-08-17 | Univ Siena | Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative. |
-
2005
- 2005-02-16 IT IT000064A patent/ITRM20050064A1/it unknown
-
2006
- 2006-02-15 RU RU2007134338/13A patent/RU2007134338A/ru not_active Application Discontinuation
- 2006-02-15 AU AU2006215260A patent/AU2006215260B2/en not_active Ceased
- 2006-02-15 US US11/814,919 patent/US8344100B2/en not_active Expired - Fee Related
- 2006-02-15 DE DE602006019057T patent/DE602006019057D1/de not_active Expired - Lifetime
- 2006-02-15 CN CNA2006800079661A patent/CN101137392A/zh active Pending
- 2006-02-15 AT AT06711432T patent/ATE492286T1/de not_active IP Right Cessation
- 2006-02-15 NZ NZ560511A patent/NZ560511A/en not_active IP Right Cessation
- 2006-02-15 MX MX2007009896A patent/MX2007009896A/es active IP Right Grant
- 2006-02-15 ES ES06711432T patent/ES2357548T3/es not_active Expired - Lifetime
- 2006-02-15 CA CA2598292A patent/CA2598292C/en not_active Expired - Fee Related
- 2006-02-15 WO PCT/IT2006/000078 patent/WO2006087756A2/en not_active Ceased
- 2006-02-15 JP JP2007554746A patent/JP4943348B2/ja not_active Expired - Fee Related
- 2006-02-15 EP EP06711432A patent/EP1848456B1/de not_active Expired - Lifetime
-
2007
- 2007-08-07 IL IL185101A patent/IL185101A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8344100B2 (en) | 2013-01-01 |
| EP1848456A2 (de) | 2007-10-31 |
| AU2006215260A1 (en) | 2006-08-24 |
| CN101137392A (zh) | 2008-03-05 |
| MX2007009896A (es) | 2008-02-12 |
| CA2598292C (en) | 2017-04-04 |
| IL185101A0 (en) | 2007-12-03 |
| WO2006087756A2 (en) | 2006-08-24 |
| NZ560511A (en) | 2010-07-30 |
| JP4943348B2 (ja) | 2012-05-30 |
| JP2008529522A (ja) | 2008-08-07 |
| RU2007134338A (ru) | 2009-03-27 |
| ITRM20050064A1 (it) | 2006-08-17 |
| US20080305091A1 (en) | 2008-12-11 |
| CA2598292A1 (en) | 2006-08-24 |
| WO2006087756A3 (en) | 2006-11-02 |
| ES2357548T3 (es) | 2011-04-27 |
| AU2006215260B2 (en) | 2011-04-28 |
| EP1848456B1 (de) | 2010-12-22 |
| DE602006019057D1 (de) | 2011-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201001054B (en) | Peptide with reduced dimer formation | |
| WO2007067506A3 (en) | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors | |
| DK1951730T3 (da) | Heteroalkylbundne pyrimidinderivater | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| WO2008031556A3 (en) | 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions | |
| WO2007058942A3 (en) | Imidazopyrazines as protein kinase inhibitors | |
| MX2009013729A (es) | Imidazopirazinas como inhibidores de proteina quinasa. | |
| MX2009005011A (es) | Imidazopirazinas como inhibidores de proteina quinasa. | |
| UA97502C2 (ru) | Кристаллическая твердая основа разагилина | |
| TW200731974A (en) | Transdermal system for verenicline | |
| PL1910338T3 (pl) | Związki heterotetracykliczne jako mimetyki TPO | |
| MY140739A (en) | 2, 6-quinolinyl derivatives, processes for preparing them and their uses | |
| MX2008002492A (es) | Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante. | |
| IL185101A0 (en) | Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity | |
| MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
| MX2008002166A (es) | Compuestos y composiciones como mimeticos de trombopoietina (tpo). | |
| WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
| WO2006133006A3 (en) | 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents | |
| TW200700085A (en) | Endoparasiticidal compositions | |
| WO2007087026A3 (en) | Solid-state form of amg 706 and pharmaceutical compositions thereof | |
| TW200638932A (en) | CCI-779 polymorph and use thereof | |
| WO2007071444A3 (en) | Esomeprazole arginine | |
| MX2007010361A (es) | Sales de fosfato de los compuestos de 6-dimetilaminometil-1(3-meto xifenil)-1, 3-dihidroxi-ciclohexano. | |
| TW200738680A (en) | Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |